Lāʻau Palekana ʻAspirin
Inoa huahana
Pahu ʻIke Lāʻau Palekana HWTS-MG050-Aspirin (Fluorescence PCR)
ʻAlapia
ʻO ka ʻAspirin, ma ke ʻano he lāʻau anti-platelet aggregation kūpono, ua hoʻohana nui ʻia i ka pale ʻana a me ka mālama ʻana i nā maʻi cardiovascular a me cerebrovascular. Ua ʻike ʻia ma ke aʻo ʻana ua ʻike ʻia kekahi mau maʻi ʻaʻole hiki ke kāohi pono i ka hana o nā platelets ʻoiai ka hoʻohana ʻana i ka aspirin haʻahaʻa lōʻihi, ʻo ia hoʻi, ke kūʻē ʻana i ka aspirin (AR). ʻO ka helu ma kahi o 50%-60%, a he ʻokoʻa lāhui maopopo. He kuleana koʻikoʻi ko Glycoprotein IIb/IIIa (GPI IIb/IIIa) i ka hōʻiliʻili platelet a me ka thrombosis koʻikoʻi ma nā wahi o ka ʻeha vascular. Ua hōʻike ʻia nā haʻawina he kuleana koʻikoʻi ko nā polymorphisms gene i ke kūʻē ʻana i ka aspirin, e kālele nui ana i nā polymorphisms gene GPIIIa P1A1/A2, PEAR1 a me PTGS1. ʻO GPIIIa P1A2 ke gene nui no ke kūʻē ʻana i ka aspirin. Hoʻololi nā mutations i loko o kēia gene i ke ʻano o nā mea loaʻa GPIIb/IIIa, e hopena ana i ka pilina ma waena o nā platelets a me ka hōʻiliʻili platelet. Ua ʻike ʻia ma ke aʻo ʻana ua ʻoi aku ka nui o ke alapine o nā alleles P1A2 i nā poʻe maʻi kūʻē i ka aspirin ma mua o nā poʻe maʻi i loaʻa ka aspirin, a ʻo nā poʻe maʻi me nā mutations homozygous P1A2/A2 he haʻahaʻa ka hopena ma hope o ka lawe ʻana i ka aspirin. ʻO nā poʻe maʻi me nā alleles P1A2 mutant e hana ʻia ana i ka stenting he subacute thrombotic event rate ʻelima mau manawa o nā poʻe maʻi P1A1 homozygous wild-type, e koi ana i nā dosis kiʻekiʻe o ka aspirin e hoʻokō i nā hopena anticoagulant. Pane maikaʻi ka allele PEAR1 GG i ka aspirin, a ʻo nā poʻe maʻi me ka genotype AA a i ʻole AG e lawe ana i ka aspirin (a i ʻole i hui pū ʻia me clopidogrel) ma hope o ka hoʻokomo ʻana o ka stent he kiʻekiʻe ka myocardial infarction a me ka make. Loaʻa i ka genotype PTGS1 GG kahi pilikia kiʻekiʻe o ke kūʻē ʻana i ka aspirin (HR: 10) a me kahi hanana kiʻekiʻe o nā hanana cardiovascular (HR: 2.55). Loaʻa i ka genotype AG kahi pilikia kūpono, a pono e uku pono ʻia ka hopena o ka lāʻau aspirin. ʻOi aku ka maʻalahi o ka genotype AA i ka aspirin, a haʻahaʻa ka hanana o nā hanana cardiovascular. Hōʻike wale nā hopena ʻike o kēia huahana i nā hopena ʻike o nā genes PEAR1, PTGS1, a me GPIIIa kanaka.
Nā Palena ʻenehana
| Ka Waihona | ≤-18℃ |
| Ola papa | 12 mahina |
| ʻAno Laʻana | ʻUhi ʻāʻī |
| CV | ≤5.0% |
| LoD | 1.0ng/μL |
| Nā Mea Hana Pili | Pili i ka mea hana ʻike ʻano I: Nā ʻōnaehana Biosystems i hoʻopili ʻia 7500 Nā ʻōnaehana PCR Manawa Maoli, QuantStudio®5 mau ʻōnaehana PCR Manawa Maoli, Nā ʻōnaehana PCR Manawa Maoli SLAN-96P (Hongshi Medical Technology Co., Ltd.), Nā ʻōnaehana ʻike PCR manawa maoli ʻo LineGene 9600 Plus (FQD-96A, ʻenehana Hangzhou Bioer), MA-6000 Mea Hoʻopololei Wela Manawa Maoli (Suzhou Molarray Co., Ltd.), ʻŌnaehana PCR Manawa Maoli BioRad CFX96, ʻŌnaehana PCR Manawa Maoli BioRad CFX Opus 96. Pili i ka mea hana ʻike ʻano II: ʻEudemonaTMʻO AIO800 (HWTS-EQ007) na Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. |
Kahe Hana
ʻO ka Micro-Test Automatic Nucleic Acid Extractor (HWTS-3006C, HWTS-3006B)) na Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
ʻO ka nui o ka hāpana i unuhi ʻia he 200μL a ʻo ka nui o ka elution i manaʻo ʻia he 100μL.







